share_log

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Furey John

SEC ·  Jul 1, 2024 16:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more